HEALTH
Gilead sets price of coronavirus drug remdesivir at $3,120 as Trump administration secures supply for 500,000 patients
HEALTH

Gilead sets price of coronavirus drug remdesivir at $3,120 as Trump administration secures supply for 500,000 patients

Published: June 29, 2020  |  6 min read, 1179 words
WRITTEN BY
Your review will affect the following:
Gilead Sciences, the maker of the first covid-19 treatment found to have worked in clinical trials, remdesivir, said Monday it will charge U.S. hospitals $3,120 for the typical patient with private insurance.Soon after the announcement, the Trump administration said it had secured nearly all of the company’s supply of the drug for use in U.S. hospitals through September, with a contract for 500,000 treatment courses, which it will make available to hospitals at Gilead’s price.Other developed countries will pay 25 percent less than the United States, a discount Gilead said reflects a need to... READ MORE
CRITIC
washingtonpost.com
Outlet Rating
washingtonpost.com
img-trusted
77%
Critic Reviews: N/A
USER
washingtonpost.com
Outlet Rating
washingtonpost.com
img-trusted
68%
User Reviews: N/A
TOP REVIEWS
There are no reviews yet.

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.